65 -- Viroseq HIV-1 Genotype System

In accordance with FAR subpart 13.106-1(b) the Centers for Disease Control and Prevention (CDC) intends to issue a sole source purchase order to Abbott Molecular Inc., in the amount of $34,128.00 for the purchase of 6 each Viroseq HIV-1 V2 Genotype Systems and 6 each Viroseq HIV-1 V2 Genotype. CDC believes that Abbott Molecular Inc is the only organization that can meet the requirements of the order. Interested parties who feel that they possess the capabilities to provide this product described above should submit a capabilities statement demonstrating their abilities to provide the product. The information received in response to this notice will be considered solely for the purpose of determining whether or not to conduct a competitive procurement. Please send your documentation to Ronnie Francis at the office identified above, by fax (770) 488-2688 or by e-mail to [email protected]. Documentation should be received within fifteen (15) days after the date of publication of this synopsis to be considered by CDC. A determination by the CDC not to compete this proposed contract based upon responses to this notice is solely within discretion on of the government.